Lorazepam Tablet
Product Images NDC 71610-229

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 71610-229). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 1 mg (71610 0229 15)

Label for Lorazepam 1 mg oral tablets, containing 15 tablets per package. The label includes storage instructions to keep the product between 20-25 degrees Celsius and in a light-resistant container. The manufacturer is AuroLife Pharma, LLC, and the labeler is Aphena Pharma Solutions - Tennessee, LLC. The label also states the drug is a Schedule IV controlled substance and RX only, with a caution about potential habit-forming effects.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical-structure (Lorazepam Str)

Chemical structure of lorazepam, showing its molecular formula C15H10Cl2N2O2 and molecular weight 321.16. The diagram depicts the arrangement of atoms in the lorazepam molecule with chlorine, nitrogen, oxygen, and carbon atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.